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ABSTRACT
Type II toxin–antitoxin (TA) systems are generally
composed of two genes organized in an operon,
encoding a labile antitoxin and a stable toxin. They
were first discovered on plasmids where they con-
tribute to plasmid stability by a phenomenon
denoted as ‘addiction’, and subsequently in bacter-
ial chromosomes. To discover novel families of
antitoxins and toxins, we developed a bioinformat-
ics approach based on the ‘guilt by association’
principle. Extensive experimental validation in
Escherichia coli of predicted antitoxins and toxins
increased significantly the number of validated
systems and defined novel toxin and antitoxin
families. Our data suggest that toxin families as
well as antitoxin families originate from distinct an-
cestors that were assembled multiple times during
evolution. Toxin and antitoxin families found on
plasmids tend to be promiscuous and widespread,
indicating that TA systems move through horizontal
gene transfer. We propose that due to their addict-
ive properties, TA systems are likely to be main-
tained in chromosomes even though they do not
necessarily confer an advantage to their bacterial
hosts. Therefore, addiction might play a major role
in the evolutionary success of TA systems both
on mobile genetic elements and in bacterial
chromosomes.
INTRODUCTION
Toxin–antitoxin (TA) systems are small genetic modules
found on bacterial mobile genetic elements as well as in
bacterial chromosomes. They appear to be speciﬁc of the
eu-bacterial and archae-bacterial worlds as no homolo-
gous sequences are detected in eukaryotic genomes
(except for the PIN toxin domain which is present in eu-
karyotes) (1). Toxins are always proteins but, based on the
nature of the antitoxin and its mode of action, TA systems
are currently divided into three classes. Antitoxins of type
I and III systems are small RNAs that inhibit either toxin
expression (type I) or activity (type III) (2,3). Antitoxins of
type II systems are proteins that inactivate toxins by
protein–protein complex formation (4). Type I and II
systems were discovered in the mid-1980s on bacterial
plasmids while type III was discovered only recently.
For type I and II systems, it became rapidly clear that
these systems were dedicated to plasmid maintenance. In
addition to several mechanisms that prevent plasmid-free
cells production, plasmids have evolved subtle molecular
systems that act by killing plasmid-free daughter bacteria
after plasmid loss. Type I and II systems are responsible
for this phenomenon denoted as post-segregational killing
or addiction (5,6). Addiction relies on the differential sta-
bility of the two components, antitoxins being less stable
than toxins. In daughter bacteria that do not inherit a
plasmid copy, the antitoxin and toxin pool is not replen-
ished. Since the antitoxin is labile, the toxin is released
from inhibition, leading to plasmid-free cell death. The
cell is thus addicted to antitoxin production and in
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type I and II systems contribute to an apparent plasmid
stabilization at the population level. An extension of this
function for type II systems is the capacity of plasmid-
encoded systems to outcompete plasmids of the same
incompatibility group devoid of TA systems (7).
Bacterial genome sequencing and database mining
revealed that homologs of type I and II systems are
found in bacterial chromosomes; the occurrence of type
II systems being surprisingly high (8–12). Analysis of their
distribution provided information regarding their evolu-
tion. While type I systems appear to have evolved by
lineage speciﬁc-duplication (13), type II systems are
thought to move from one genome to another by horizon-
tal gene transfer (9,14). The number of type II systems
varies greatly not only from one bacterial species to
another, but also between isolates from the same species
(9,15). The function(s) of chromosomally encoded type I
and II systems remain(s) unclear (2,16,17). Although it has
been proposed that type II systems might serve as stress
response modules, convincing data are still lacking (18).
Recent studies have shown that type II systems are
involved in the stabilization of large genomic frag-
ments (19) and of integrative conjugative elements (20),
indicating that some TA systems might have retained
their addictive properties.
Genetic organization of known type II TA systems is
quite conserved. Typically, these systems comprise two
small genes organized in an operon, the upstream gene
encoding the antitoxin. General features such as small
size of both components (31–204 amino acid for antitoxins
and 41–206 amino acid for toxins) and short intergenic
regions separating the two genes ( 20 to +30nt) are
also well conserved (9). In general, antitoxins are com-
posed of two domains, an amino-terminal domain respon-
sible for DNA binding and a carboxy-terminal domain
responsible for toxin interaction. The antitoxin–toxin
protein complex, in which the toxin is inactive, is also
responsible for negative autoregulation. Toxins typically
are small, stable proteins that inhibit either replication by
interacting with DNA-gyrase, or translation by cleaving
messenger RNAs (mRNAs) or inhibiting elongation.
Classiﬁcation of the type II TA systems is based on the
amino acid sequence similarity of the toxins, each toxin
family being associated with a speciﬁc antitoxin family.
Thus, type II systems are currently divided into 10
families (8,9). However, a few examples of ‘hybrid’ asso-
ciations of a toxin from one family and an antitoxin be-
longing to another family have recently been characterized
(21,22). Furthermore, novel putative families of toxins and
antitoxins (i.e. not homologous to the 10 families) have
been predicted by bioinformatics approaches recently and
some were found to be associated with known toxin or
antitoxin families, indicating that ‘hybrid’ systems might
be more common than originally thought (12,23,24). In
fact, one such prediction in Escherichia coli K-12 was
recently validated experimentally (8). Thus, predictions
are that the type II TA systems are much more
abundant and diversiﬁed than what is currently described.
To evaluate this diversity, a bioinformatics approach was
developed to explore prokaryotic genomes and to identify
novel toxins and antitoxins. From our predictions, 18
antitoxin and 23 toxin sequences originating from
different bacterial species were validated experimentally
in E. coli, signiﬁcantly increasing the number of families
of type II antitoxins and toxins. Therefore, we propose to
refer to antitoxin and toxin families independently instead
of referring to TA system families.
MATERIALS AND METHODS
Bioinformatics approach
This approach is described in details in Supplementary
‘Materials and Methods’ section and summarized in
Figure 1.
Bacterial strains, plasmids and media
Bacterial strains. The following E. coli strains were used:
MC1061 (F
  araD139, D(ara-leu)7696, galE15, galK16,
D(lac)X74, rpsL (Str
r), hsdR2 (rK
 mK
+), mcrA mcrB1)
(25), MG1655 (rph1 ilvG rfb-50) (26), DJ624 Dara
(MG1655 lacX74 mal::lacI
q) (27) and DJ624 sﬁA::lacZ
(this work).
Plasmids. The following plasmids were used and their
relevant characteristics are indicated. The pBAD33
vector (p15A, Cm
r, pBAD promoter) (28), the pBAD33-
yoeB plasmid (pBAD33 derivative containing the yoeB
toxin gene under the control of the pBAD promoter)
(29), the pKK223-3 vector (ColE1, Amp
r, pTac
promoter) (30) and the pLac-staby vector
(DelphiGenetics, Belgium) were used in this work.
Media. Luria-Bertani liquid and agar medium (LB)
(Invitrogen) as well as M9 minimal liquid and agar
medium (KH2PO4 (22mM), Na2HPO4 (42mM), NH4Cl
(19mM), MgSO4 (1mM), CaCl2 (0.1mM), NaCl (9mM)
supplemented with casamino acids [0.2% except for me-
thionine incorporation (0.05%)] and carbon sources
[glycerol, glucose or arabinose (1%)].
Antibiotics. Antibiotics were added at the following con-
centrations: chloramphenicol, 20mg/ml; ampicillin,
100mg/ml.
Experimental validation of novel toxins and antitoxins
sequences
The experimental validation of the putative novel toxins
and antitoxins families relies on a simple assay: expression
of the putative toxins should cause growth inhibition while
co-expression with their putative cognate antitoxins
should restore normal growth. To that end, antitoxin
and toxin candidate genes were cloned in compatible ex-
pression vectors under the control of inducible promoters.
Toxins cloning. Predicted toxin genes were cloned in the
pBAD33 vector, under the control of the arabinose-
inducible pBAD promoter. The predicted toxin coding se-
quences (CDS) were ampliﬁed from bacterial genomic
DNA using the appropriate start and stop primers
(Supplementary Table S1). Start primers carry a canonical
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(PCR) products were digested by XbaI and PstI, except
the sauT3COL, nspT5PC7120, speT2TIGR4, speT1TIGR4 amp-
liﬁcation products that were digested by SacI and KpnI;
and ccrT3CB15 that was digested by XbaI and SalI.
Digested products were ligated into the pBAD33 vector
cleaved with the appropriate restriction enzymes. Toxins
that did not confer an unambiguous growth inhibition
phenotype when expressed from the pBAD33 vector
were cloned in the pKK223-3 vector under the control
of the pTac promoter. The PCR products were digested
by EcoRI and PstI and cloned in the pKK223-3 vector
cleaved with the same restriction enzymes.
Antitoxins cloning. Predicted antitoxin genes were cloned
in the pLac-staby vector and/or in the pKK223-3 vector,
which places the antitoxin genes under the control of the
pLac and pTac promoters, respectively. Expression from
both promoters is induced by isopropyl b-D-1-thiogalacto-
pyranoside (IPTG) addition. Predicted CDSs were
ampliﬁed from genomic DNA using the appropriate
start and stop primers (Supplementary Table S1) and
PCR products were ligated in the pLac-staby vector.
The predicted antitoxins that failed to counteract the
growth inhibition of their cognate toxins were cloned in
the pKK223-3 vector under pTac control. The PCR
products were digested by EcoRI and PstI and cloned in
the pKK223-3 vector cleaved with the same restriction
enzymes. To test the activity of antitoxins associated
with toxins cloned in the pKK223-3 vector, the cognate
antitoxin genes were cloned in the pBAD33 vector. PCR
products were digested by XbaI and PstI and cloned in the
pBAD33 digested with the same restriction enzymes.
Killing/rescue assay. The DJ624Dara strain was trans-
formed by toxin-encoded plasmids and/or by antitoxin-
encoded plasmids and the control vectors. Transformants
were grown overnight in M9 liquid medium containing
glucose (1%) and the appropriate antibiotics. Overnight
cultures were diluted 100-fold in M9 medium containing
glucose (1%) and the appropriate antibiotics and grown at
37 C to an OD 600nm of 0.2. Dilutions (10
0–10
6) were
plated on M9 plates containing either glucose (1%) or
arabinose (1%) and IPTG (1mM) and the appropriate
antibiotics. Plates were incubated overnight at 37 C.
SOS induction
The DJ624 sﬁA::lacZ strain containing the pBAD33,
pBAD-parERK2, pBAD-ccrT4CB15 or pBAD-atuT1c58
plasmids was grown in M9 medium supplemented with
glucose (1%) and chloramphenicol to an OD 600nm of
0.1. Cultures were centrifuged and pellets resuspended in
M9 medium containing arabinose (1%) andchlorampheni-
col. After 120min of induction, aliquots were taken to
perform b-galactosidase assays as described in ref. 31.
35S-methionine incorporation
The DJ624Dara strain containing the pBAD33 vector and
its derivates containing the experimentally validated toxin
genes and appropriate controls were grown in M9 medium
supplemented with glycerol (1%) at 37 C. Toxin
over-expression was induced at an OD 600nm of 0.1 by
adding arabinose (1%). After 180min of induction, 1ml
aliquots were taken and 5mCi of
35S-methionine was
added. After 2min of incubation at 37 C, 500ml aliquots
were removed and added to tubes containing 5ml of cold
10% TCA and left 20min on ice. Samples were then
ﬁltered on nitrocellulose ﬁlters (0.45mm) saturated with
the non-labeled precursor using a glass funnel. Filters
were then washed in 10% TCA and air-dried. Filter-
retained material was counted in 10ml of scintillation
liquid (Ready Protein +) in a liquid scintillation counter
(Beckman). Translation rate was normalized to the
35S-methionine incorporated by the control strain
(pBAD33 vector).
RESULTS
Detecting ‘similar’ and potentially novel toxins and
antitoxins
We collected the antitoxin and toxin sequences of type II
systems that were experimentally validated and character-
ized at the time we started this work. In addition to the
relBE, parDE, vapBC, mazEF, phd-doc, higAB, hipBA,
omega-epsilon-zeta and ccd systems and their homologs,
sequences of the vapXD system were added to our data set
even though this system is poorly documented (32). We
also included sequences of the parDEDL933-parE3,
paaA2-parE2 (33) and yafNO systems that were identiﬁed
by our procedure and tested as ‘proof of concept’. Note
that yafNO characterization was published during the
course of this work (34). The hicAB system was not
included since it was not validated at the time we started
this analysis (8). Our query data set was therefore com-
posed of 24 sequences of antitoxin and 24 sequences of
toxin that were denoted as ‘original’ sequences
(Supplementary Table S2). We performed a comprehen-
sive PSI-BLAST search (see Supplementary ‘Materials
and Methods’ section) on 2181 prokaryotic genomes and
detected more than 10000 sequences. These sequences
were grouped in eight toxin super-families and nine of
antitoxin (Supplementary Tables S3 and S4).
Based on the conservation of type II systems organiza-
tion, we developed an exploratory bioinformatics ap-
proach based on the ‘association by guilt’ of orphan
toxins or antitoxins (i.e. not paired with ‘original’ anti-
toxins or toxins) to discover novel sequences potentially
showing antitoxin or toxin activities (Figure 1 and see
Supplementary ‘Materials and Methods’ section for de-
tails). These sequences were grouped into protein
families based on their similarities (see Supplementary
‘Materials and Methods’ section for the detailed proced-
ure and parameters). As a result, we distinguished two
types of predicted antitoxin or toxin sequences: those be-
longing to a family composed of proteins of unknown
function which were called AG (for ‘associated by
guilt’), and those ‘associated by guilt’ but present in a
family containing at least one ‘original’ sequence or one
sequence presenting similarity with ‘original’ sequences
(denoted as ‘similar’, see Supplementary ‘Materials and
Nucleic Acids Research, 2011,Vol.39, No. 13 5515Figure 1. Association by guilt bioinformatics approach. Detection of ‘associated by guilt’ (AG) sequences (A). ‘Similar’ sequences (purple box) to the
48 ‘original’ sequences (white box) were detected by PSI-BLAST searches using the indicated parameters (gray boxes) and a database composed of
2181 genome sequences (blue cylinder). First round: AG toxins and antitoxins denoted as AG1 (orange box) were identiﬁed by paring of the ‘similar’
sequences using the indicated parameters (gray box). Number and type of sequences are indicated (T for toxin, A for antitoxin and U for
unassigned). Second round: AG1 sequences were used as query for a second round of detection using the same parameters as in the initial steps
to identify AG-like sequences (orange box). AG2 sequences were identiﬁed by pairing the AG-like sequences. Number and type of sequences are
indicated. Pair deﬁnition (B). An additional round of pair deﬁnition was performed using sequences detected in (A) using the indicated parameters
(gray box). Protein families (C). Protein families (green box) were generated by grouping all the proteins present in the dataset using the Markov
clustering algorithm (MCL) with the indicated parameters (gray boxes). Names of ‘original’ or ‘similar’ sequences were propagated to the AG
proteins within the same protein family. These sequences were then deﬁned as ‘associated by guilt and annotated’ (AGA).
5516 Nucleic Acids Research, 2011,Vol.39, No. 13Methods’ section for details). Super-family names of these
‘original’ and/or ‘similar’ sequences were transferred to
these AG sequences and they were denoted consequently
‘associated by guilt and annotated’ (AGA).
Experimental validation of predicted toxins and antitoxins
Our bioinformatics exploratory procedure led to the pre-
diction of a large number of novel AG and AGA toxins
and antitoxins located upstream and/or downstream of
orphan ‘similar’ and originating from numerous bacterial
species.
Experimental validation of these AG and AGA se-
quences was carried out in E. coli using a simple Kill/
Rescue assay, in which expression of the toxin gene is
expected to inhibit cell growth while co-expression of the
toxin and antitoxin genes restores growth.
The toxin and antitoxin sequences were cloned in com-
patible vectors, under the control of different inducers (see
‘Materials and Methods’ section). These sequences were
placed in the same genetic context, i.e. RBS and ATG as
start codon, to achieve a comparable level of expression,
although we cannot rule out that some genes are less ex-
pressed than others as we did not measure expression
levels.
Predicted toxins
Twenty-three AG toxins were experimentally tested. Eight
of them are paired with sequences ‘similar’ to ‘original’
antitoxins (Supplementary Table S5). Expression of the
putative BceT5E33L, SpyT210270 and LmoT1EGD-e toxins
did inhibit E. coli growth. Among the upstream open
reading frames (ORFs) predicted to be antitoxins, only
BceA5E33L, which is associated with the BceT5E33L
toxin, turned out to be a functional antitoxin belonging
to the HigA super-family of antitoxins. For the SpyT210270
toxin, the antitoxin activity of the downstream SpyA210270
ORF, although not predicted by our approach, was tested.
Co-expression of SpyA210270 relieved SpyT210270-
mediated cell growth inhibition. In this case, the antitoxin
gene is located downstream of the toxin gene. For the
third toxin that inhibits E. coli growth, LmoT1EGD-e,
none of the ﬂanking ORFs showed antitoxin activity.
Seven AG toxins associated with AGA antitoxins belong-
ing to the HigA super-family were tested (Supplementary
Table S6). Expression of four of them (SmeT11021,
MavT1K10, SpyT19429 and SpyT310270) inhibited E. coli
growth. However, only two of the predicted antitoxins
(SmeA11021 and MavA1K10) relieved the growth inhibition
mediated by their cognate toxins. For the SpyT19429 and
SpyT310270 toxins, we were unable to detect antitoxin activity
for their ﬂanking ORFs.
Eight AG toxins associated with eight AG antitoxins
were experimentally tested (Supplementary Table S7).
Expression of BceT1E33L, SpyT110270, SpyT1M1 and
EcoT1EDL933 resulted in E. coli growth inhibition and
co-expression of their paired antitoxins relieved growth
inhibition (Figure 2).
One predicted pair (MGAS10270 Spy0568 and
Spy0569) presented a particular phenotype. This pair is
composed of sequences similar to the E. coli hicAB
system (8). HicA was shown to be a toxin cleaving
mRNAs and HicB was shown to be its antitoxin. Our
prediction was opposite: Spy0568, the S. pyogenes HicB
homolog was predicted to be a toxin and Spy0569, the
HicA homolog, the antitoxin. Surprisingly, expression of
both proteins was toxic for E. coli (data not shown). We
therefore renamed Spy0568 as SpyT410270 and Spy0569 as
SpyT510270. The ﬂanking ORFs being located on the com-
plementary strand, we did not check their antitoxic
activity.
Predicted antitoxins
Eleven AG antitoxins were experimentally tested. Eight
predicted antitoxins are associated with sequences ‘similar’
to ‘original’ toxins (Supplementary Table S8). Expression
of these toxins inhibited E. coli growth except for the
RPC4130 ORF. The seven cognate antitoxins relieved
the toxicity mediated by their associated toxins.
Three of these antitoxins (CcrA1CB15, SpeA2TIGR4 and
CcrA4CB15) were validated by other groups during the
course of this work, although their annotation turned
out to be incorrect (9,35). The CcrA1CB15 antitoxin is
associated with a sequence similar to ParE and was
described as being a ParDRK2-like antitoxin in
Caulobacter crescentus (36). We were unable to detect
any sequence similarity between this sequence and the
ParDRK2 antitoxin. The second case concerns the
SpeA2TIGR4 antitoxin, which is associated with a toxin
from the RelE family in Streptococcus pneumoniae. This
ORF was named RelB2spn in a previous work (35).
However, again, we were unable to detect any sequence
similarity between this sequence and RelBK-12. The last
case concerns the ccrA4CB15-ccrT4CB15 system that was
annotated as relBE2 in C. crescentus (9) and experimen-
tally analyzed (36). The CcrT4CB15 toxin belongs to the
ParE/RelE super-family. We showed that expression of
Figure 2. The ecoA1-ecoT1EDL933 and the nspA5-nspT5PC7120 pairs
constitute TA systems. The DJ624Dara strain containing the pBAD33
and pLac-staby plasmids (1), the pBAD33-ecoT1EDL933 and pLac-staby
plasmids (2), the pBAD33-ecoT1EDL933 and pLac-staby-ecoA1EDL933
plasmids (3), the pBAD33-nspT5PC7120 and pLac-staby plasmids (4)
or the pBAD33-nspT5PC7120 and pLac-staby- nspA5PC7120 plasmids
(5) were grown in log phase in M9 medium supplemented with
glucose (1%) and appropriate antibiotics. Serial dilutions (as indicated)
were spotted on LB plates containing arabinose (1%) and IPTG
(1mM). Plates were incubated overnight at 37 C.
Nucleic Acids Research, 2011,Vol.39, No. 13 5517this toxin induces the SOS response, although less efﬁciently
than ParERK2 (Figure 3), conﬁrming our predictions and
indicating that CcrT4CB15 is a ParE-like toxin. The
associated CcrA4CB15 antitoxin, however, does not show
any similarities to ‘original’ antitoxins. Thus, these three
antitoxins represent novel sequences associated with
‘similar ‘toxins that present a growth inhibition phenotype
do not show any similarities with ‘original’ antitoxins and
were not described previously. The AtuA1c58 antitoxin is
associated with AtuT1c58, which belongs to the ParE/RelE
toxin super-family. Expression of this toxin induces the
SOS system, indicating that AtuT1c58 is a ParE-like
toxin (Figure 3). The NspA5PC7120 and AfuA2DSM4304
antitoxins are paired with toxins from the VapC super-
family and the SpeA3TIGR4 antitoxin is associated with a
toxin belonging to the Doc super-family.
Three AG antitoxins associated with AGA toxins
were experimentally tested (Supplementary Table S6).
Expression of these three toxins (NspT1PC7120,
NspT2PC7120 and NeuT1C91) resulted in E. coli growth
inhibition and co-expression of their associated antitoxins
relieved this inhibition (Figure 2). Two of these toxins
belong to the VapC super-family and the other to the
ParE/RelE super-family.
Thus, this approach led to the validation of 23 toxins
and 18 antitoxins. For 5 of the 23 toxins, we were unable
to identify the cognate antitoxin, suggesting that they
might be solitary toxins or that expression levels of some
of the antitoxins might be too low to rescue the toxic
phenotype. Eleven of the 34 predicted toxins did not
affect E. coli growth; it is possible that, as mentioned
above, expression levels are too low; these sequences
might be false-positives (not related to toxins) or they
might be ‘true’ toxins but only for their natural host and
not for E. coli.
Toxin activities
To gain insights into the mode of toxicity of the novel vali-
dated toxins, several tests were performed. Cell morph-
ology was observed by microscopy and SOS induction,
transcription as well as translation rates were measured
in E. coli overexpressing the active toxins. In addition to
the novel toxins, we also tested the AGA NspT1PC7120 and
NspT5PC7120 toxins belonging to the VapC super-family in
order to conﬁrm this annotation. Neither cell morph-
ology, SOS induction nor transcription rates were
affected by toxin overexpression (data not shown and
Supplementary Figure S1). However, expression of these
toxins drastically reduced
35S-methionine incorporation
(from 10% to 30% as compared to the control vector)
(Figure 4). These data show that all of the tested toxins
affect translation. In addition, preliminary data seem to
indicate that expression of some of these toxins induces
mRNA cleavage in E. coli (data not shown).
Evolutionary relationships between novel and ‘original’
super-families
Six of the 23 toxins validated experimentally deﬁne four
novel super-families (Table 1). These super-families were
denoted as Gin (for growth inhibition).
Three of the novel toxins constitute the GinA
super-family (SpyT110270, SpyT210270 and BceT1E33L).
The GinB super-family is composed of the SmeT11021
novel toxin as well as the YgjN toxin, which was identiﬁed
in E. coli during the course of this work (37). This toxin
was considered as a homolog of RelE (37). However, while
we detected sequence similarity between SmeT11021 and
YgjN (data not shown, E-value: 10e-7), we were unable
to detect any sequence similarity between SmeT11021 and
the members of the ParE/RelE super-family. The GinC
and GinD super-families are composed of SpyT1M1 and
BceT5E33L, respectively. Regarding the solitary toxins,
they deﬁne four novel super-families (data not shown).
Twelve of the 18 antitoxins that were experimentally
validated deﬁne 11 novel antitoxin super-families that
Figure 4. Overexpression of the novel toxins inhibits translation in
E. coli. The DJ624Dara strain containing the pBAD33 (1), pBAD-
parERK2 (2), pBAD-yoeB (3), pBAD-ecoT1EDL933 (4), pBAD-mavT1K10
(5), pBAD-spyT110270 (6), pBAD-spyT210270 (7), pBAD-bceT1E33L (8),
pBAD-smeT11021 (9), pBAD-spyT1M1 (10), pBAD-bceT5E33L (11),
pBAD-nspT1PC7120 (12), pBAD-nspT2PC7120 (13), pBAD-spyT410270
(14), pBAD-spyT510270 (15), pBAD-spyT310270 (16), pBAD-spyT19429
(17) and pBAD-lmoT1EGD-e (18) were grown in M9 medium. After in-
duction of toxin expression by arabinose addition, cultures were labeled
with
35S-methionine. Translation rate was measured as described in
‘Materials and Methods’ section.
Figure 3. Overexpression of the CcrT4CB15 and AtuT1C58 toxins induce
the SOS system in E. coli. The DJ624 sﬁA::lacZ strain containing
the pBAD33 (1), pBAD-parERK2 (2), pBAD-ccrT4CB15 (3) or pBAD-
atuT1c58 (4) plasmids were grown in M9 medium. After induction
of toxin expression by arabinose addition, samples were taken to
perform b-galactosidase assays as described in ‘Materials and
Methods’ section.
5518 Nucleic Acids Research, 2011,Vol.39, No. 13are unrelated to the ‘original’ super-families. They were
named Fiz for full toxin neutralization (Table 2).
Association between antitoxin and toxin super-families
In general, a large number of predicted toxin sequences
are associated with antitoxin AG sequences (Figure 5).
Three main categories can be deﬁned: toxin super-families
that have multiple partners (>4) such as the large ParE/
RelE, VapC and CcdB/MazF super-families and the
smaller GinA super-family (Figure 5A). The second
category is composed of Doc, GinC and Zeta super-
families. Sequences belonging to these super-families are
associated with three different antitoxin super-families
(Figure 5B). In the last category, toxin super-families are
associated with AG sequences and a second super-family,
Phd for the YafO super-family and HigA for the HipA,
GinB and GinD super-families.
As observed for the predicted toxins, a large number of
predicted antitoxins are associated with AG sequences
(Figure 6). Categories similar to those deﬁned for toxin
super-families can be deﬁned. Three super-families of anti-
toxin are promiscuous and associate with ﬁve or more
toxin families i.e. the large PhD and HigA super-families
(Figure 6A). The second category groups super-families
that associated with three or four different toxin
super-families such as the RelB and FizD super-families
(Figure 6B). Most of the antitoxin super-families are quite
restrictive in their associations (Figure 6C). They are
associated with AG sequences and a second toxin super-
family. Five of the novel super-families associate exclu-
sively with a speciﬁc toxin super-family (FizB, FizF,
FizI, FizJ and FizK) (Figure 6D).
Phyletic and genomic distribution of the toxin and
antitoxin super-families
Phyletic distribution varies from one super-family to the
other. The ParE/RelE, Zeta, VapC, Doc, CcdB/MazF,
HipA and GinB super-families of toxins are widely dis-
tributed in bacterial phyla, although GinB is not detected
in Firmicutes (Figure 7A). At least 70% of their members
are detected in Proteobacteria, Firmicutes (except GinB),
Cyanobacteria and Actinobacteria. The remaining se-
quences are detected in various phyla, with all of them
except HipA and GinB being present in Archae. The
GinA and VapD super-families, on the other hand, are
restricted to a smaller number of phyla. Note that the
VapD sequences are neither detected in Firmicutes nor
in Archae. The GinC, YafO and GinD are speciﬁc to a
single phylum. Most of the toxin sequences are located in
chromosomes (Supplementary Figure S2A), except for the
VapD sequences that are detected on plasmids (40%) and
GinA sequences on phages (30%). The GinC, YafO and
GinD sequences are detected neither on plasmids nor on
phages.
As observed for the toxin super-families, phyletic distri-
bution of the antitoxin super-families varies from one
super-family to the other (Figure 7B). The HigA, FizA,
FizB, FizC, Phd, VapB, PasA and RelB super-families
appear widely distributed in bacterial phyla. At least 70
% of the members of these super-families are found in
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Nucleic Acids Research, 2011,Vol.39, No. 13 5519Proteobacteria, Firmicutes and Cyanobacteria (except for
RelB sequences). The remaining 30% varies depending on
the family, with members of HigA, FizA, Phd, VapB and
PasA super-families being detected in Archae. The other
super-families appear to be much more restricted. A
majority of the FizG sequences are detected in
Cyanobacteria. Sequences of FizE and FizF super-families
are distributed in two phyla: Proteobacteria and Green
sulfur bacteria. Members of the CcdA, ParD and FizI
super-families are exclusively found in Proteobacteria,
while those of VapX and Epsilon are restricted to
Firmicutes and FizH to Archae. The only representative
of FizK super-family is found in Cyanobacteria.
Regarding their genomic location (Supplementary
Figure S2B), more than 85% of the sequences are
located on chromosomes except for the RelB, FizF,
CcdA and ParD super-families with 20–40% of the se-
quences being located on plasmids. The Epsilon super-
family represents an exception with its 11 representative
sequences being found only on plasmids.
Genome size and number of type II TA systems are not
correlated
Figure 8 shows that there is no signiﬁcant correlation
between the number of predicted toxin and antitoxin se-
quences and the total number of ORFs predicted in a
given genome. Even the smallest genomes of some of the
intracellular obligate species seem to contain predicted
toxin and antitoxin sequences (Table 3). While Buchnera
and Chlamydia/Chlamydophyla genomes are devoid of
predicted toxin and antitoxin sequences, some
Rickettsias (such as R. bellii OSU 85-389, R. bellii
RML369-C, R. akari or R. felis) contain more than 20
predicted sequences, representing between 1.8% and
2.6% of the total number of ORFs. Interestingly, the
number of predicted toxins and antitoxins in the
Rickettsia genus is quite variable (0–36). Variability is
also found within the Wolbachia genus (0–6 predicted se-
quences). For the 20 bacterial isolates with the highest
content of toxin and antitoxin predicted sequences, it
varies from 37 to 97 per genome, representing from
0.8% to 2.5% with respect to the total number of ORFs
(Supplementary Table S9). These bacteria belong to four
different phyla (Proteobacteria, Cyanobacteria, Green
sulfur and Actinobacteria). High genome plasticity
appears to be a common theme for most of these strains
(described for 12 over 20, e.g. Microcystis aeruginosa,
Gleobacter violaceum and Nitrosomanas europeae). They
also tend to have a versatile metabolism (6 over 20, e.g.
Nitrosomanas europeae, Rhodopseudomas palustris and
Azoarcus sp.) or a particular metabolism (4 over 20, e.g.
Geobacter uraniireducens, Pelodictyon phaeoclathratiforme
and Caulobacter sp.). Two isolates are symbionts
(Verminephrobacter eiseniae and Photorabdus luminescens)
and another is part of phototrophic bacterial consortia
(C. chlorochromatii). Five of the strains belong to the
Table 2. Occurrence of 20 antitoxin super-families in 2181 prokaryotic genomes
Antitoxin superfamilies (n=10829)
Phd
(n=955)
RelB
(n=304)
PasA
(n=656)
VapB
(n=665)
HigA
(n=3351)
VapX
(n=10)
CcdA
(n=74)
Epsilon
(n=11)
ParD
(n=10)
FizA
(n=1962)
‘Original’
sequences
Phd, YefM,
Axe, PasB,
StbD, YafN,
RelB307
RelBK-12,
DinJ,
Paa1
PasA, YdcD,
ParDEDL933
VapB, MvpA,
MazE,
ChpBI,
PemI
HigA, HipB VapX CcdAF Epsilon ParDRK2 –
Validated
‘similar’
sequences
NT NT NT NT YgjM
a
BceA5E33L
NT NT NT NT –
Validated AGA
sequences
NT NT NT NT SmeA11021
MvA1K10
NT NT NT NT –
Validated AG
sequences
NT NT SpeA2TIGR4 SpeA3TIGR4 EcoA1EDL933 NT NT NT NT SpyA21070
Antitoxin superfamilies (n=10829) Total
FizB
(n=1542)
FizC
(n=1121)
FizD
(n=103)
FizE
(n=26)
FizF
(n=10)
FizG
(n=9)
FizH
(n=8)
FizI
(n=6)
FizJ
(n=5)
FizK
(n=1)
20
‘Original’
sequences
––– – –– – –– – 2 4
Validated ‘similar’
sequences
––– – –– – –– – 1
Validated AGA
sequences
––– – –– – –– – 2
Validated AG
sequences
CcrA1CB15 SpyA1M1 NeuA1C91 AtuA1C58 SpyA110270 NspA2PC7120,
NspA5PC7120
AfuA2DSM4304 CcrA4CB15 BceA133L NspA1PC7120 15
The HigA super-family might contain a signiﬁcant number of false-positive sequences that were selected on the basis of the HTH-XRE domain found
in the ‘original’ HigA sequence.
n represents the number of sequences; NT for not tested.
aIndicates that the YgjM antitoxin was validated during the course of this work (37).
5520 Nucleic Acids Research, 2011,Vol.39, No. 13Mycobacterium tuberculosis complex and are pathogenic
(or deriving from a pathogenic strain in the case of
M. tuberculosis H37Ra).
DISCUSSION
Discovering novel toxin and antitoxin sequences
The ‘association by guilt’ approach was already used to
predict novel TA systems by Makarova et al. (24). The
approach we used in this work allowed the identiﬁcation
of sequence pairs presenting unusual features such as a
total absence of similarity with the ‘original’ sequences,
a larger size for both the antitoxins and toxins (>200
amino acid) and larger intergenic distances (up to
300bp). Comparison between their data and ours
indicates that our approach predicted their sequences
(data not shown) but, more importantly, conﬁrmed that
there are many more toxins and antitoxin families not
related to ‘original’ ones or simply uncharacterized yet,
than previously thought and that remain to be experimen-
tally studied. The successful experimental validation of
some of our predictions is a direct proof of the results
presented in the two works.
Activities of type II toxins
Quite unexpectedly, the novel toxins identiﬁed in this
work are all translation inhibitors. We cannot exclude
that a bias might have been introduced by the experimen-
tal validation of foreign genes in E. coli. Toxins targeting
speciﬁc pathways might not be toxic for E. coli and there-
fore not validated by our Killing/rescue assay. The
counter-argument is that if these genes are involved in
stable maintenance of mobile genetic elements and move
through horizontal transfer, toxins should target
conserved mechanisms to ensure their function and main-
tenance in different bacterial hosts. ‘Original’ toxins in-
hibiting translation use a variety of mechanisms from
cleavage of free-RNAs, cleavage of mRNAs during trans-
lation, inhibition of elongation by 30S binding and by
EF-Tu phosphorylation (38–40), and it remains to be
shown whether novel toxins will extend this list of
activities. Mechanisms of action of these toxins are cur-
rently being investigated in our laboratory.
Origin and evolution of type II TA systems
Evolution of the TA systems remains largely unknown.
While some authors proposed that these systems might
derive from a common ancestor (41), other groups are in
favor of several ancestors (10,12). Our data indicate that
the validated toxins (both ‘original’ and those discovered
in this analysis) constitute 12 unrelated super-families. No
structural homologs could be detected for the novel toxins
in the PDBsum structure database except for SpyT1M1.
The structure of its homolog is unrelated to type II
toxins. This indicates that the novel toxins do not share
any evolutionary relationship with ‘original’
super-families, although they are functionally related.
However, only the resolution of their three-dimensional
structures will unambiguously answer this question since
similar structures have been detected for toxins that do
not show signiﬁcant sequence similarity (42). Subsequent
divergence is observed for toxins within the ParE/RelE
and CcdB/MazF super-families as they acquired different
activities (DNA-gyrase inhibitors and mRNA-
interferases).
For the antitoxins, our data indicate that they form 20
unrelated super-families. Further analyses will be required
to deﬁne whether or not these antitoxins have a
DNA-binding domain. Retracing antitoxin evolution
might be complex since antitoxins are composed in
general of two independent domains, an amino-terminal
DNA-binding domain and a carboxy-terminal
toxin-binding domain. DNA-binding domains might be
recruited from or by other types of activities totally unre-
lated to antitoxins. A variation on the theme is observed in
Figure 5. Associations of toxin super-families. The 12 toxin
super-families are indicated above the pie chart. Each section of the
pie chart represents the relative abundance of antitoxin sequences be-
longing to a given super-family associated with toxin sequences. Each
antitoxin super-family is represented by a speciﬁc color. In (A), toxin
super-families that are associated with multiple antitoxin super-families
(>4). In (B), toxin super-families that are associated with three different
antitoxin super-families. In (C), toxin super-families that are associated
with AG sequences and another antitoxin super-family. Associations
occurring at less than 1% were not considered for clarity.
Nucleic Acids Research, 2011,Vol.39, No. 13 5521Figure 6. Associations of antitoxin super-families. The 20 antitoxin super-families are indicated above the pie chart. Each section of the pie chart
represents the relative abundance of toxin sequences belonging to a given super-family associated with antitoxin sequences. Each toxin super-family is
represented by a speciﬁc color. In (A), antitoxin super-families that are associated with multiple toxin super-families (ﬁve or more). In (B), antitoxin
super-families that are associated with three or four different toxin super-families. In (C), antitoxin super-families that are associated with AG
sequences and another toxin super-family. In (D), antitoxin super-families that are associated with a speciﬁc toxin super-family or to AG sequences.
Associations occurring at <1% were not considered for clarity.
Figure 7. Phyletic distribution of toxin and antitoxin super-families. Sequences of toxin super-families (A) and antitoxin super-families (B) are
detected in the bacterial phyla indicated at the left of the ﬁgure in different proportions: not detected (white), 0.1–20% (gray), 20.1–60% (dark
gray), above 60.1% (black).
5522 Nucleic Acids Research, 2011,Vol.39, No. 13the case of three-component systems. In these systems
[epsilon-omega-zeta (43) and paaR1-paaA1-parE3 (33)],
DNA-binding and antitoxin activities are encoded by
two separated polypeptides. Molecular mechanisms
underlying transcriptional regulation of three-component
systems remain to be determined.
Abundance and diversity
Another level of diversity is observed for antitoxin
and toxin associations. Sequences of the RelE/ParE,
CcdB/MazF and VapC super-families are paired with
antitoxin sequences of the RelB, Phd, MazE and PasA
super-families, supporting the idea that antitoxins and
toxins were assembled multiple times as suggested previ-
ously (12). Sequences belonging to these super-families are
abundant and present on plasmids. Other super-families
are less promiscuous in their association. The reason is
unclear, although super-families such as GinC, GinD,
YafO, FizH or FizI are less represented and tend to be
phyla- and chromosome-speciﬁc (although we cannot ex-
clude that some are located on genomic islands), which
might reduce their possibilities of association. However,
although CcdA, Epsilon and ParD antitoxin sequences are
present on plasmids, and therefore should be prone to
horizontal gene transfer, they are phyla-speciﬁc and not
abundant. Thus, what makes the evolutionary success of a
given antitoxin or toxin super-family is still largely
unknown. We have to keep in mind the biases introduced
by the fact that a majority of the fully sequenced genomes
available at NCBI are of Proteobacteria (745/1566
genomes) and that genomic islands within chromosomes
remain difﬁcult to identify.
Nevertheless, in general, these entities are abundant in
bacterial chromosomes. Some genomes contain as much
as 97 predicted antitoxin and toxin sequences
(Supplementary Table S9), representing 1.5% with
respect to the total number of CDSs. An even higher per-
centage is observed in some obligate intracellular bacterial
genomes (Table 3). Predicted antitoxin and toxin se-
quences in R. belii and R. felis represent as much as
2.2% to 2.6%, respectively. Interestingly, these strains
also contain a high number of repeat sequences (3.7%
and 4.4%, respectively) and other genes indicative of
genome plasticity (e.g. phage-related genes, transposases)
(44,45). In contrast, other strains of the Rickettsia genus
such as R. typhi and R. prowezaki, appear to be devoid of
predicted antitoxin and toxin sequences (Table 3).
Interestingly, both strains are closely related in the
Rickettsia phylogeny and have undergone massive reduc-
tive evolution (a general phenomenon observed in obligate
intracellular bacteria) as compared to R. felis and R. bellii
(46). The absence of TA systems in some obligate intra-
cellular bacteria might be due to massive gene loss. The
comparison of M. leprae and its free-living relative
M. tuberculosis complex strains supports this idea (one
predicted sequence versus 43–45) (Table 3 and
Supplementary Table S9). A contrario, a high content of
TA systems might reﬂect an intense gene ﬂux
(Supplementary Table S9). Interestingly, R. felis carries
a putative conjugative plasmid (44) and might still be
Table 3. Predicted antitoxin and toxin sequences in intracellular
obligate species
Bacterial species Phyla CDS in
genome
Predicted
A and
T (%)
Buchnera aphidicola str. APS Proteobacteria 564 0
Buchnera aphidicola str. Bp Proteobacteria 504 0
Buchnera aphidicola str. Cc Proteobacteria 357 0
Buchnera aphidicola str. Sg Proteobacteria 546 0
Chlamydia muridarum Nigg Chlamydiae 904 0
Chlamydia trachomatis 434/Bu Chlamydiae 874 0
Chlamydia trachomatis A/HAR-13 Chlamydiae 911 0
Chlamydia trachomatis D/UW-3/CX Chlamydiae 895 0
Chlamydia trachomatis
L2b/UCH-1/proctitis
Chlamydiae 874 0
Chlamydophila abortus S26/3 Chlamydiae 932 0
Chlamydophila caviae GPIC Chlamydiae 998 0
Chlamydophila felis Fe/C-56 Chlamydiae 1005 0
Chlamydophila pneumoniae AR39 Chlamydiae 1112 0
Chlamydophila pneumoniae CWL029 Chlamydiae 1052 0
Chlamydophila pneumoniae J138 Chlamydiae 1069 0
Chlamydophila pneumoniae TW-183 Chlamydiae 1113 0
Rickettsia akari str. Hartford Proteobacteria 1259 23 (1.8)
Rickettsia bellii OSU 85-389 Proteobacteria 1476 32 (2.2)
Rickettsia bellii RML369-C Proteobacteria 1429 26 (1.8)
Rickettsia canadensis str. McKiel Proteobacteria 1093 1 (0.09)
Rickettsia conorii str. Malish 7 Proteobacteria 1374 13 (0.9)
Rickettsia felis URRWXCal2 Proteobacteria 1400 36 (2.6)
Rickettsia massiliae MTU5 Proteobacteria 968 16 (1.7)
Rickettsia prowazekii str. Madrid E Proteobacteria 835 0
Rickettsia rickettsii str. ’Sheila Smith’ Proteobacteria 1345 14 (1.0)
Rickettsia rickettsii str. Iowa Proteobacteria 1384 13 (0.9)
Rickettsia typhi str. Wilmington Proteobacteria 838 0
Mycobacterium leprae TN Actinobacteria 1605 1 (0.06)
Wigglesworthia glossinidia Proteobacteria 611 0
Wolbachia endosymbiont of
Drosophila melanogaster
Proteobacteria 1195 6 (0.5)
Wolbachia endosymbiont strain
TRS of Brugia malayi
Proteobacteria 805 0
Wolbachia pipientis Proteobacteria 1275 2 (0.2)
For each genome, the total number of CDS is indicated.
The total number of ‘similar’ and AGA sequences belonging to the
super-families described in Supplementary Tables S2 and S3 were con-
sidered with the exception of those belonging to the Zeta and HigA
super-families as many false-positive sequences are suspected.
The percentage of predicted sequences with respect to the total number
of CDS in the genome is indicated between brackets.
A for antitoxin, T for toxin.
Figure 8. No correlation between the total number of CDS and the
number of predicted antitoxin and toxin sequences. Only ‘original’ and
‘similar’ antitoxin and toxin sequences were considered.
Nucleic Acids Research, 2011,Vol.39, No. 13 5523prone to horizontal gene transfer. This could possibly
explain the presence of predicted toxin and antitoxin se-
quences in this strain.
As a conclusion, we propose that toxin and antitoxin
genes have emerged and assembled multiple times during
evolution. Associated with mobile genetic elements, TA
systems promote their stability and propagate efﬁciently
within the bacterial world. Because of their addictive
properties, they integrate stably in bacterial chromosomes
without providing necessarily selective advantages to their
hosts. Interestingly, most of the toxin families are transla-
tion inhibitors, suggesting that this activity might have
been selected rather than more detrimental ones such as
DNA-gyrase inhibitors.
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